134 related articles for article (PubMed ID: 2465215)
1. The inhibitor of F VIIa in plasma measured with a sensitive chromogenic substrate assay: comparison with antithrombin, protein C and heparin cofactor II in a clinical material.
Abildgaard U; Sandset PM; Andersson TR; Odegaard OR; Rosĕn S
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):274-7. PubMed ID: 2465215
[TBL] [Abstract][Full Text] [Related]
2. High plasma levels of extrinsic pathway inhibitor and low levels of other coagulation inhibitors in advanced cancer.
Lindahl AK; Sandset PM; Abildgaard U; Andersson TR; Harbitz TB
Acta Chir Scand; 1989 Aug; 155(8):389-93. PubMed ID: 2596246
[TBL] [Abstract][Full Text] [Related]
3. Extrinsic pathway inhibitor in elective surgery: a comparison with other coagulation inhibitors.
Sandset PM; Høgevold HE; Lyberg T; Andersson TR; Abildgaard U
Thromb Haemost; 1989 Nov; 62(3):856-60. PubMed ID: 2595660
[TBL] [Abstract][Full Text] [Related]
4. Chromogenic substrate assay of extrinsic pathway inhibitor (EPI): levels in the normal population and relation to cholesterol.
Sandset PM; Larsen ML; Abildgaard U; Lindahl AK; Odegaard OR
Blood Coagul Fibrinolysis; 1991 Jun; 2(3):425-33. PubMed ID: 1932528
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of activated coagulation factor VII by normal human plasma.
Dahl PE; Abildgaard U; Larsen ML; Tjensvoll L
Thromb Haemost; 1982 Dec; 48(3):253-6. PubMed ID: 7164015
[TBL] [Abstract][Full Text] [Related]
6. Circadian variations in natural coagulation inhibitors protein C, protein S and antithrombin in healthy men: a possible association with interleukin-6.
Undar L; Ertuğrul C; Altunbaş H; Akça S
Thromb Haemost; 1999 Apr; 81(4):571-5. PubMed ID: 10235441
[TBL] [Abstract][Full Text] [Related]
7. Heparin induces release of extrinsic coagulation pathway inhibitor (EPI).
Sandset PM; Abildgaard U; Larsen ML
Thromb Res; 1988 Jun; 50(6):803-13. PubMed ID: 3413731
[TBL] [Abstract][Full Text] [Related]
8. Heparin cofactor II determination--levels in normals and patients with hereditary antithrombin III deficiency and disseminated intravascular coagulation.
Tran TH; Duckert F
Thromb Haemost; 1984 Oct; 52(2):112-6. PubMed ID: 6395434
[TBL] [Abstract][Full Text] [Related]
9. Extrinsic pathway inhibitor--the key to feedback control of blood coagulation initiated by tissue thromboplastin.
Sandset PM; Abildgaard U
Haemostasis; 1991; 21(4):219-39. PubMed ID: 1794748
[TBL] [Abstract][Full Text] [Related]
10. Laboratory determination of heparin cofactor II.
Ezenagu LC; Brandt JT
Arch Pathol Lab Med; 1986 Dec; 110(12):1149-51. PubMed ID: 3778142
[TBL] [Abstract][Full Text] [Related]
11. [Standardization of the laboratory method for antithrombin activity measurement].
Okajima K
Rinsho Byori; 2002 Mar; 50(3):283-6. PubMed ID: 11985057
[TBL] [Abstract][Full Text] [Related]
12. Functional properties of factor VIIa/tissue factor formed with purified tissue factor and with tissue factor expressed on cultured endothelial cells.
Almus FE; Rao LV; Rapaport SI
Thromb Haemost; 1989 Dec; 62(4):1067-73. PubMed ID: 2617454
[TBL] [Abstract][Full Text] [Related]
13. Engineered recombinant factor VII Q217 variants with altered inhibitor specificities.
Chang YJ; Hamaguchi N; Chang SC; Ruf W; Shen MC; Lin SW
Biochemistry; 1999 Aug; 38(34):10940-8. PubMed ID: 10460149
[TBL] [Abstract][Full Text] [Related]
14. Extrinsic pathway inhibitor (EPI) released to the blood by heparin is a more powerful coagulation inhibitor than is recombinant EPI.
Lindahl AK; Abildgaard U; Larsen ML; Staalesen R; Hammer AK; Sandset PM; Nordfang O; Beck TC
Thromb Res; 1991 Jun; 62(6):607-14. PubMed ID: 1926055
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody specific for tissue factor pathway inhibitor-factor Xa complex: its characterization and application to plasmas from patients with disseminated intravascular coagulation and pre-disseminated intravascular coagulation.
Ohkura N; Soe G; Kohno I; Kumeda K; Wada H; Kamikubo Y; Shiku H; Kato H
Blood Coagul Fibrinolysis; 1999 Sep; 10(6):309-19. PubMed ID: 10493212
[TBL] [Abstract][Full Text] [Related]
16. Antithrombin-mediated inhibition of factor VIIa-tissue factor complex by the synthetic pentasaccharide representing the heparin binding site to antithrombin.
Lormeau JC; Herault JP; Herbert JM
Thromb Haemost; 1996 Jul; 76(1):5-8. PubMed ID: 8819242
[TBL] [Abstract][Full Text] [Related]
17. Assay of dermatan sulfate cofactor (heparin cofactor II) activity in human plasma.
Abildgaard U; Larsen ML
Thromb Res; 1984 Aug; 35(3):257-66. PubMed ID: 6547786
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor.
Petersen LC; Sprecher CA; Foster DC; Blumberg H; Hamamoto T; Kisiel W
Biochemistry; 1996 Jan; 35(1):266-72. PubMed ID: 8555184
[TBL] [Abstract][Full Text] [Related]
19. Human plasma extrinsic pathway inhibitor activity: II. Plasma levels in disseminated intravascular coagulation and hepatocellular disease.
Warr TA; Rao LV; Rapaport SI
Blood; 1989 Aug; 74(3):994-8. PubMed ID: 2787683
[TBL] [Abstract][Full Text] [Related]
20. Studies of the factor Xa-dependent inhibitor of factor VIIa/tissue factor (extrinsic pathway inhibitor) from cell supernates of cultured human umbilical vein endothelial cells.
Warn-Cramer BJ; Almus FE; Rapaport SI
Thromb Haemost; 1989 Feb; 61(1):101-5. PubMed ID: 2665164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
